More doubt on tight ICU glucose control

>
By  |  March 24, 2009 | 

In the highly anticipated NICE-SUGAR trial, over 6000 med-surg ICU patients from 42 hospitals were randomized to tight (81-108) or conventional (<180) glucose control. The primary outcome (90 day death) occurred in 28% of the tight, versus 25% of the conventional group, and severe hypoglycemia (<40) occurred in 7% versus <1%. Tight glucose control in adult ICU patients may be harmful, and goals should be liberalized to keep glucose 140-180 (time-weighted mean in the conventional group was 142) (abstract)

Share This Post

Leave A Comment

For security, use of Google's reCAPTCHA service is required which is subject to the Google Privacy Policy and Terms of Use.

About the Author: Danielle Scheurer

Danielle Scheurer, MD, MSCR, SFHM is a clinical hospitalist and the Chief Quality Officer at the Medical University of South Carolina in Charleston, South Carolina, where she also serves as Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She is also the President of SHM's Board of Directors and previously served as Physician Editor of The Hospitalist, SHM's monthly newsmagazine.

Categories

Related Posts

By Angela Castellanos, MD
January 5, 2021 |  0
While spring 2020 feels like a lifetime ago, COVID-19 is still with us. Unfortunately, this winter has brought more infections, hospitalizations, and death rates that eclipse what many saw last spring. But this time, while the headlines are back about hospitals running low on PPE, ICU bed shortages, and long lines for testing, we now […]
By W. Michael Brode, MD
December 15, 2020 |  2
This article is part of a series in The Hospital Leader written by members of the Division of Hospital Medicine at Dell Medical School at The University of Texas in Austin, exploring lessons learned from the coronavirus pandemic and outlining an approach for creating COVID-19 Centers of Excellence. Evidence on emerging treatments for COVID-19 has […]
July 31, 2020 |  0
While all of us see patients who smoke in their 70s or 80s, due to their limited lifespan from COPD, DM, malignancy, etc., and their expressed wishes to continue tobacco, we keep our admonitions to a minimum. We accept our patient has become learned enough through life to make their own decisions and accept whatever […]
Go to Top